Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral polymicrobial biofilm refers to a highly organized and structured community of multiple microbial species—including bacteria, fungi, and sometimes archaea or protozoa—adhering to oral surfaces (teeth, mucosa, implants). These communities are embedded in an extracellular polymeric substance (EPS) matrix that provides protection from host immunity and antibiotics. Oral biofilms play a central role in initiating and perpetuating a wide variety of oral diseases, including dental caries, periodontitis, and peri-implant infections, and are characterized by metabolic cooperation, virulence factor production, and immune modulation. Their complex nature and resilience pose significant therapeutic challenges, necessitating innovative strategies beyond conventional antimicrobial use. It is important to note that "Oral polymicrobial biofilm" is not a conventional molecular target or receptor; rather, it describes a collective microbial structure. This entry is therefore not a druggable target in the traditional sense (e.g., receptor, enzyme, ion channel), but instead represents a pathophysiological niche or community. This makes "is_incorrect: true" the appropriate designation for molecular target databases seeking single, defined biomolecules.
Disruption of cell membranes (e.g., by chlorhexidine, antimicrobial peptides); Inhibition of bacterial protein synthesis (e.g., doxycycline); Inhibition of DNA replication (e.g., ciprofloxacin); Inhibition of cell wall synthesis (e.g., amoxicillin); Reactive oxygen species generation; Extracellular matrix destabilization.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral polymicrobial biofilm.